Abbott Sells IVD, Point-Of-Care Diagnostics To GE For $8.13 Bil.
This article was originally published in The Gray Sheet
Executive Summary
With GE's $8.13 billion cash purchase of Abbott Laboratories' core in vitro diagnostics unit Jan. 18, the corporate giant is betting it can accelerate growth in a business still recovering from protracted regulatory challenges in the U.S
You may also be interested in...
Abbott’s New Diagnostics Chief Confident In A Future Without GE
Abbott has created a new position to head its diagnostics units, signaling its commitment to the business now that an $8 billion buy-out from General Electric is off the table
Abbott’s New Diagnostics Chief Confident In A Future Without GE
Abbott has created a new position to head its diagnostics units, signaling its commitment to the business now that an $8 billion buy-out from General Electric is off the table
GE And Abbott Walk Away From $8 Billion Diagnostics Deal
Abbott says it will continue to manage its core laboratory and point-of-care diagnostics business for the long-term following the collapse of an $8.13 billion deal to sell the unit to General Electric